BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1840356)

  • 1. Kidney transplantation and malignant diseases.
    Grosmanová T; Tomsu M; Konecný K; Pesula E; Bachleda P
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():335-42. PubMed ID: 1840356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["De novo" malignant tumors in kidney transplant receptors].
    Robles JE; Aguera LG; Rosell D; Abad JI; Rodríguez-Rubio FI; Zudaire JJ; Errasti P; Berian JM
    Actas Urol Esp; 1994 Apr; 18(4):266-70. PubMed ID: 7976711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanomas in renal transplant recipients.
    Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
    Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignant neoplasia and kidney transplantation. Retrospective analysis of data on the population having kidney transplantation with de novo neoplasia in the setting of the AIRT].
    Stallone G; Infante B; Schena A; Grandaliano G; Di Paolo S; Scolari MP; Stefoni S; Zanazzi M; Salvadori M; Savazzi AM; Albertazzi A; Cornella C; Turello E; Schena FP
    G Ital Nefrol; 2003; 20(6):611-4. PubMed ID: 14732914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results with single pediatric donor kidney transplants in adult recipients.
    Modlin C; Novick AC; Goormastic M; Hodge E; Mastrioanni B; Myles J
    J Urol; 1996 Sep; 156(3):890-5. PubMed ID: 8709356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kidney transplantation and tumors].
    Lácha J; Jirka J; Nouza M; Chadimová M; Rossmann P
    Cas Lek Cesk; 1994 Sep; 133(18):562-5. PubMed ID: 7954667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal graft survival in patients with systemic lupus erythematosus].
    Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
    Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of cancer after kidney transplant: results from the North Italy transplant program.
    Pedotti P; Cardillo M; Rossini G; Arcuri V; Boschiero L; Caldara R; Cannella G; Dissegna D; Gotti E; Marchini F; Maresca MC; Montagnino G; Montanaro D; Rigotti P; Sandrini S; Taioli E; Scalamogna M
    Transplantation; 2003 Nov; 76(10):1448-51. PubMed ID: 14657684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of oncocytoma in transplanted kidney].
    Descotes JL; Pasquier D; Bayle F; Teil E; Rambeaud JJ
    Prog Urol; 2001 Feb; 11(1):91-4. PubMed ID: 11296656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant tumours after renal transplantation.
    Tóth A; Alföldy F; Járay J; Hidvégi M; Perner F
    Acta Chir Hung; 1992-1993; 33(3-4):211-6. PubMed ID: 1345378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant neoplasms and kidney transplantation].
    Serrallach N; Riera LL; Franco E; Aguiló F; Muñoz J; López-Costea MA; Camps N; Serra J; González C; Castelao AM
    Actas Urol Esp; 1994 Sep; 18(8):801-7. PubMed ID: 7998508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo renal cell carcinoma of native kidney in renal transplant recipients.
    Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
    Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bronchogenic carcinoma in patients undergoing solid organ transplant. The role of surgery].
    Padilla J; Cerón J; Peñalver JC; Jordá C; Pastor E; de Aguiar K
    Cir Esp; 2009 Aug; 86(2):101-4. PubMed ID: 19476930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urothelial cancer in patients with Endemic Balkan Nephropathy (EN) after renal transplantation.
    Zivcić-Cosić S; Grzetić M; Valencić M; Oguić R; Maricić A; Dordević G; Balen S; Orlić L; Racki S; Fuckar Z
    Ren Fail; 2007; 29(7):861-5. PubMed ID: 17994456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer incidence after immunosuppressive treatment following kidney transplantation.
    Andrés A
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):71-85. PubMed ID: 15978827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.